Logo Image
|Webcasts|May 4, 2021

Through Obstacles and Beyond: The Value of Building Strategic Site Relationships

Author(s)IQVIA

*** Wednesday, May 4, 2021 at 11am EDT *** Driving faster site activation for any clinical trial requires close interactions with sponsors to seamlessly execute a breadth of requirements to stay compliant while delivering to new levels of efficiencies ***On demand available after final airing until May 4, 2022***

Register free: http://www.appliedclinicaltrialsonline.com/act_w/covid

​Event Overview:

The outbreak of COVID-19 has affected each of us in many ways. To develop a vaccine and successful treatments in record time after lockdown, sponsors had to adapt their clinical trial processes, site relationships and means to interact with patients. To ensure clinical trial continuity, much has been altered in the field of site setup, recruitment and unique site support.

Join this timely and insightful webcast to understand how, by leveraging a valued site setup and engagement strategy throughout the clinical development process, IQVIA has worked with sponsors to engage the right sites, provided support to sites so they remain relevant, and initiated trials in record time by incorporating innovative approaches that adapt to and overcome obstacles such as COVID-19 and other industry challenges. Learn more on

3 Key take-aways:

  1. The criticality of a unique site relationship is to drive efficiencies and support appropriate staffing levels while maintaining quality delivery when multiple protocols enroll at the same time
  2. How technology, data analytics and AI/ML are helping drive faster site activation and high-quality patient recruitment at the site and in the community
  3. The need to integrate clinical research as a care option for the benefit of patients, bringing to life the importance of site location, patient voice, and diversity and inclusion in clinical research

Speakers: Mark Brown, VP, Global Patient and Site Solutions, IQVIA

Christy Godwin, Global Head, Business Development, Avacare Clinical Research Network, IQVIA

Casey Orvin, SCRS President, IQVIA

Time and Date: Wednesday, May 4, 2021 at 11am EDT

On demand available after final airing until May 4, 2022.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/covid

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more